About Glyqa

About company

GLYQA ('sweet' in Greek) is a mobile phone-based product, offering symptom management and smart interventions for complications arising from Diabetes and associated comorbidities. Diabetes is one of the diseases with profound complications, including heart disease, stroke, kidney failure, loss of limbs, and retinopathy. Diabetes affects 25.8 million people which is 8.3% of the U.S. population, costing us about $245 Billion. They are the first product to combine predictive modeling, machine learning and care practices to introduce interventions for Diabetes and associated complications.